Low-dose and high-dose acetylsalicylic acid for patients undergoing carotid endarterectomy: a randomised controlled trial
The LancetPublished 1 June 1999
D. Wayne Taylor, Henry J.M. Barnett, R. Brian Haynes, Gary G. Ferguson, David L. Sackett, Kevin E. Thorpe
Citations540
SJR quartileQ1
SJR score12.11
SNIP22.72
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
The risk of stroke, myocardial infarction, and death within 30 days and 3 months of endarterectomy is lower for patients taking 81 mg or 325 mg acetylsalicylic acid daily than for those taking 650 mg or 1300 mg.
Abstract
The risk of stroke, myocardial infarction, and death within 30 days and 3 months of endarterectomy is lower for patients taking 81 mg or 325 mg acetylsalicylic acid daily than for those taking 650 mg or 1300 mg.
Keywords
MedicineBiochemistry, Genetics and Molecular Biology
New England Journal of MedicineBeneficial Effect of Carotid Endarterectomy in Symptomatic Patients with High-Grade Carotid Stenosis
8,368 Citations1991H. J. M. Barnett
Carotid endarterectomy is highly beneficial to patients with recent hemispheric and retinal transient ischemic attacks or nondisabling strokes and ipsilateral high-grade stenosis of the internal carotid artery.
New England Journal of MedicineBenefit of Carotid Endarterectomy in Patients with Symptomatic Moderate or Severe Stenosis
3,600 Citations1998Henry J.M. Barnett, D. Wayne Taylor +11 more
Benefit of carotid endarterectomy was greatest among men, patients with recent stroke as the qualifying event, and patients with hemispheric symptoms, and decisions about treatment for patients in this category must take into account recognized risk factors.
The LancetRandomised trial of endarterectomy for recently symptomatic carotid stenosis: final results of the MRC European Carotid Surgery Trial (ECST)
3,351 Citations1998
Carotid endarterectomy is indicated for most patients with a recent non-disabling carotid-territory ischaemic event when the symptomatic stenosis is greater than about 80%, but age and sex should also be taken into account in decisions on whether to operate.
The LancetMRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis
3,265 Citations1991Charles Warlow
The main concern was to avoid disabling or fatal events, and, among severe stenosis patients, 3.7% had a disabling stroke (or died) within 30 days of surgery, an extra 1.1% surgery versus 8.4% control (p less than 0.0001).
Journal of Neurology Neurosurgery & PsychiatryThe United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results.
1,212 Citations1991Barbara Farrell, Jon Godwin +2 more
The odds of suffering a major stroke, myocardial infarction or vascular death were 15% less in the combined aspirin groups compared with the placebo group which is compatible with the continuing overview of all the similar trials of antiplatelet drugs.
New England Journal of MedicineA Randomized Trial of Aspirin and Sulfinpyrazone in Threatened Stroke
960 Citations1978The Canadian Cooperative Study Group
StrokeControlled trial of aspirin in cerebral ischemia.
634 Citations1977William S. Fields, Noreen A. Lemak +2 more
It cannot be inferred from this study that aspirin prevents stroke because when end points were restricted to death or cerebral or retinal infarction, there was no statistically significant differential between the aspirin and placebo treatments.
Stroke"AICLA" controlled trial of aspirin and dipyridamole in the secondary prevention of athero-thrombotic cerebral ischemia.
611 Citations1983Marie‐Germaine Bousser, E Eschwège +5 more
It is concluded that, in patients comparable to those defined in the protocol, Aspirin (1 g) has a significantly beneficial effect in the secondary prevention of atherothrombotic cerebral infarction.
The LancetSwedish Aspirin Low-dose Trial (SALT) of 75 mg aspirin as secondary prophylaxis after cerebrovascular ischaemic events
549 Citations1991The Salt Collaborative Group
It is found that a low dose (75 mg/day) of aspirin significantly reduces the risk of stroke or death in patients with cerebrovascular ischaemic events.
New England Journal of MedicinePreliminary Report: Findings from the Aspirin Component of the Ongoing Physicians' Health Study
519 Citations1988The Steering Committee of the Physicians' Health Study Research Group
BMJCollaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy
511 Citations1994Antiplatelet Trialists' Collaboration
Antiplatelet therapy (chiefly aspirin alone or aspirin plus dipyridamole) greatly reduces the risk of vascular occlusion in a wide range of patients at high risk of this complication.
StrokeThe Clinical Meaning of Rankin ‘Handicap’ Grades After Stroke
459 Citations1995Rob de Haan, M. Limburg +3 more
The Rankin Scale is not a pure handicap measure but should be viewed as a global functional health index with a strong accent on physical disability that is useful as a simple and time-efficient outcome measure in largescale multicenter trials.
PubMedAmbulatory and inpatient procedures in the United States, 1994.
436 Citations1997R Pokras, Lola Jean Kozak +1 more
Females had more procedures than males did and the rate of procedures increased with age in both ambulatory and inpatient settings in the United States during 1994.
The LancetIMPAIRED PLATELET/CONNECTIVE-TISSUE REACTION IN MAN AFTER ASPIRIN INGESTION
377 Citations1967HarveyJ. Weiss, LouisM Aledort
In normal men, aged 25-40 years, ingestion of 3 g.
PubMedAmbulatory and inpatient procedures in the United States, 1995.
302 Citations1998Lola Jean Kozak, Maria Owings
Females had more procedures than males, and the rate of procedures increased with age in ambulatory and inpatient settings, in the United States during 1995.
StrokeEffects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin.
205 Citations1992Hideo Tohgi, Shu Konno +3 more
The findings suggest that different doses of aspirin may be necessary to prevent thrombogenesis induced by different triggers of different strengths and that 40 mg/day aspirin is able to inhibit a large proportion of maximum thromboxane A2 release provoked acutely, with the prostaglandin I2 synthesis being little affected.
StrokeA Systematic Comparison of the Risks of Stroke and Death Due to Carotid Endarterectomy for Symptomatic and Asymptomatic Stenosis
182 Citations1996Peter M. Rothwell, J Slattery +1 more
Mortality and the risk of stroke and/or death due to carotid endarterectomy are significantly lower for asymptomatic than symptomatic stenosis, consistent across virtually all studies and are likely to be widely generalizable.
The LancetEFFECT OF ASPIRIN IN AMAUROSIS FUGAX
106 Citations1971Michael J. Harrison, Jeff Meadows +2 more
Two patients with amaurosis fugax were treated with 600 mg.
ProstaglandinsPlatelet aggregation and thromboxane release induced by arachidonic acid, collagen, ADP and platelet-activating factor following low dose acetylsalicylic acid in man
54 Citations1986Leonie Küster, Jürgen C. Frölich
It is concluded that a daily dose of 50 mg ASA would suffice in blocking platelet TXA2 production and aggregation induced by most physiological agents.